Search
Search Funnelback University
- Refined by:
- Date: 2022
21 -
30 of
183
search results for news |u:www.enterprise.cam.ac.uk
Fully-matching results
-
Challenges and Opportunities for Commercialisation of Research out of …
https://www.enterprise.cam.ac.uk/challenges-and-opportunities-for-commercialisation-of-research-out-of-the-social-sciences/25 Oct 2022: The push for commercialising research in the social sciences is relatively new compared to STEM subjects. ... Market-based solutions to address societal problems from academic research should not be presented as a new agenda. -
Develop a commercial opportunity – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/19 Jan 2022: become new areas of research for you. -
Impact Insight: Kalamna CIC – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-kalamna-cic/12 May 2022: Dr Khalil has spent her career researching how young Arabic learners can be engaged through a new approach to Arabic phonics. ... A licensing arrangement managed by Cambridge Enterprise now enables Kalamna CIC to launch the toolkit to an international -
NMC coating information sheet (Gre-7694-20)
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/03/NMC-coating-information-sheet-Gre-7694-20.pdf9 Feb 2022: Professor Dominic Wright leads internationally-respected research into new synthetic routes to a broad range of main group and transition metal compounds. -
Centessa Pharmaceuticals – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/centessa-pharmaceuticals-three-portfolio-companies-merge-into-a-new-pharmaceutical-giant/11 Apr 2022: 16 February 2022. Centessa Pharmaceuticals: Three portfolio companies merge into a new pharmaceutical giant. ... The new company was launched with $250 million in Series A financing—one of the biggest in recent years—led by blue-chip investors. -
Murid herpesvirus-4 (MuHV 4) Antibodies - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/murid-herpes-virus-4-antibodies/9 May 2022: Mouse monoclonal antibodies raised against Murid herpesvirus-4 (MuHV 4) developed at the University of Cambridge. -
CRoSS Programme: Research Impact Ideation Workshop – Cambridge…
https://www.enterprise.cam.ac.uk/events/cross-programme-research-impact-ideation-workshop-2/2 Dec 2022: Join an engaged and action-focussed community as we explore new models for social science impact on global challenges. -
Cambridge Enterprise licenses unique new device for cancer diagnosis…
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-licences-unique-new-device-for-cancer-diagnosis/15 Nov 2022: 1 November 2022. Cambridge Enterprise licenses unique new device for cancer diagnosis. -
The University of Cambridge ecosystem – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/about/our-role-within-the-cambridge-ecosystem/within-the-university/20 Jul 2022: i-Teams. The i-Teams innovation programme brings together multi-disciplinary teams of post-graduates with industry mentors and real Cambridge inventions to assess the commercial viability of new technologies and ... We currently run 2 courses a term, -
Impact Insight: iKVA – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-ikva/12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: iKVA. Share:. This Impact Insight video tells the story behind the creation of iKVA. iKVA is a University of Cambridge spin-out that uses artificial intelligence (AI) to
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.